Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCapital Limited Regulatory News (CAPD)

Share Price Information for Capital Limited (CAPD)

Share Price is delayed by 15 minutes
Get Live Data
114.50    0.50 (0.44%)
Bid:
113.50
Ask:
114.50
Spread: 1.00 (0.881%)
Market Cap: £258.43m
CAPD Live PriceLast checked at - London Stock Exchange

Intraday Capital Limited Share Chart

Completed Secondary Placing

4 Apr 2019 09:40

RNS Number : 1358V
Peel Hunt LLP
04 April 2019
 

4 April 2019

Completed Secondary Placing in Capital Drilling Limited

NOT FOR DISTRIBUTION IN THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS), CANADA, JAPAN, AUSTRALIA OR THE REPUBLIC OF SOUTH AFRICA. THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

Placing of 10,000,000 ordinary shares in Capital Drilling Limited ("Capital Drilling" or the "Company")

Craig Burton, a founder and former director of Capital Drilling, (the "Seller") has sold, subject to completion, 10,000,000 ordinary shares in the Company (the "Placing Shares") at a price of 48 pence per share (the "Placing"). The Placing Shares represent approximately 7.3% of the Company's issued share capital.

Settlement of the Placing is expected to occur on a T+2 basis on or around 8 April 2019.

The Company will not receive any proceeds from the Placing.

The Ordinary Shares held by the Seller following completion of the Placing, amounting to 10,795,394 Ordinary Shares will be subject to a six month lock-up which is subject to certain exceptions and may otherwise only be waived with the consent of Peel Hunt LLP and Tamesis Partners LLP (the "Joint Bookrunners").

Market Abuse Regulation

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this announcement via a regulatory information service, this inside information is now considered to be in the public domain.

 

Enquiries:

Peel Hunt LLP +44 207 478 8900

Ross Allister, James Bavister, David McKeown

Tamesis Partners LLP +44 203 882 2868

Charlie Bendon, Richard Greenfield

 

DISCLAIMER

This announcement and the information contained herein may not be published, distributed or transmitted, directly or indirectly, in the United States (including its territories and possessions), Canada, Australia, Japan or the Republic of South Africa or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This announcement and the information contained herein are for information purposes only and do not constitute or form part of any offer of securities for sale or a solicitation of an offer to purchase securities in the United States, Australia, Canada, Japan, the Republic of South Africa or any other jurisdiction.

In the United Kingdom, this announcement is only directed at persons who are qualified investors (as defined below) and (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as "Relevant Persons"). This announcement is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.

In member states of the European Economic Area (EEA) which have implemented the Prospectus Directive (each, a "Relevant Member State"), this announcement and any offer if made is directed exclusively at persons who are "qualified investors" within the meaning of the Prospectus Directive ("qualified investors"). For these purposes, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression "2010 PD Amending Directive" means Directive 2010/73/EU.

The distribution of this announcement and the offering or sale of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken that would permit an offering of securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions. No prospectus or offering document has been or will be prepared in connection with the Placing. Any investment decision to buy securities in the Placing must be made solely on the basis of publicly available information. Such information is not the responsibility of and has not been independently verified by any of the Seller, the Joint Bookrunners or any of their respective affiliates.

The Joint Bookrunners are authorised and regulated by the Financial Conduct Authority in the United Kingdom. The Joint Bookrunners are acting only for the Seller in connection with the Placing and will not be responsible to anyone other than the Seller for providing the protections offered to their respective clients nor for providing advice in relation to the Placing or any matters referred to in this announcement.

In connection with any offering of the Placing Shares, the Joint Bookrunners and/or any respective affiliates may take up a portion of the securities in the offering as a principal position and in that capacity may retain, purchase or sell for their own account such securities. The Joint Bookrunners do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCIIMPTMBJMMRL
Date   Source Headline
8th Jun 20269:12 amRNSDirector Dealing
20th May 202612:10 pmRNSResults of Annual General Meeting
27th Apr 202610:31 amRNS-RInvestor Presentation via Investor Meet Company
22nd Apr 20267:00 amRNSPublication of 2025 Sustainability Report
21st Apr 20267:00 amRNSQ1 2026 Trading Update
17th Apr 20261:40 pmRNSNotice of AGM and Proxy Form
14th Apr 20269:44 amRNSIssue of Equity and Director / PDMR Shareholding
19th Mar 20267:01 amRNSPublication of Annual Report 2025
19th Mar 20267:00 amRNSFull Year Results
18th Mar 20267:00 amRNSLondon Stock Exchange Presentation Details
25th Feb 20267:00 amRNSContracts Update
20th Jan 20267:00 amRNSQ4 2025 Trading Update
18th Dec 20252:02 pmRNSNotification of Major Holdings
18th Dec 20252:02 pmRNSNotification of Major Holdings
18th Dec 20257:56 amRNSTR-1 Notification of Major Holdings
16th Dec 202510:47 amRNSDirector Dealing
11th Dec 202511:56 amRNSResult of General Meeting
26th Nov 202512:28 pmRNSDirector Dealing
26th Nov 20259:10 amRNSTR-1 Notification of Major Holdings
24th Nov 20251:57 pmRNSPublication of Circular and Notice of GM
21st Nov 20259:52 amRNSCorrection: Results of Placing
21st Nov 20257:00 amRNSResults of Placing
20th Nov 20254:45 pmRNSProposed Equity Raise to Support Growth Strategy
20th Oct 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
16th Oct 20257:00 amRNSQ3 2025 Trading Update
6th Oct 20253:42 pmRNSDirector Dealing
14th Aug 20257:00 amRNSH1 2025 Results (Unaudited)
7th Aug 20257:00 amRNSLondon Stock Exchange Presentation
17th Jul 20257:08 amRNSQ2 2025 Trading Update and Increased Guidance
19th Jun 20257:00 amRNSContracts Update
12th Jun 20251:58 pmRNSDirector Declaration
28th May 202512:58 pmRNSNotification of Major Holdings
21st May 20252:08 pmRNSResults of Annual General Meeting
24th Apr 202511:44 amRNSPublication of 2024 Sustainability Report
23rd Apr 202511:05 amRNSNotice of AGM and Proxy Form
23rd Apr 20257:00 amRNSQ1 2025 Trading Update
10th Apr 20251:18 pmRNSIssue of Equity and Director / PDMR shareholding
4th Apr 202510:39 amRNSDirector Dealing
3rd Apr 202511:27 amRNSDirectors' Dealing
2nd Apr 20257:00 amRNSCapital signs mining services contract at Reko Diq
27th Mar 20257:04 amRNSFull Year Financial Results
27th Mar 20257:00 amRNSPublication of Annual Report 2024
25th Mar 20258:06 amRNSFY24 Results: Investor Presentation
10th Mar 20257:00 amRNSCompany update
27th Jan 20253:08 pmRNSNotification of Major Holdings
20th Jan 20257:00 amRNSTrading and Operational Update
9th Dec 20242:43 pmRNSNotification of major holdings
21st Nov 20247:00 amRNSAppointment of Non-Executive Director
12th Nov 20243:43 pmRNSTR-1 Notification of Major Holdings
17th Oct 20247:00 amRNSQ3 2024 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.